{{Rsnum
|rsid=3136685
|Gene=CCR7
|Chromosome=17
|position=40563547
|Orientation=minus
|GMAF=0.2847
|Gene_s=CCR7
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 1.8 | 24.8 | 73.5
| HCB | 17.5 | 40.9 | 41.6
| JPT | 8.0 | 37.2 | 54.9
| YRI | 27.9 | 49.0 | 23.1
| ASW | 19.3 | 45.6 | 35.1
| CHB | 17.5 | 40.9 | 41.6
| CHD | 15.7 | 44.4 | 39.8
| GIH | 5.9 | 36.6 | 57.4
| LWK | 22.7 | 54.5 | 22.7
| MEX | 8.6 | 25.9 | 65.5
| MKK | 37.2 | 43.6 | 19.2
| TSI | 2.9 | 37.3 | 59.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=23168091
|Title=Chemokine Ligand 5 (CCL5) and Chemokine Receptor (CCR5) Genetic Variants and Prostate Cancer Risk among men of African Descent:  A Case-Control Study
|OA=1
}}

{{PMID Auto
|PMID=19196101
|Title=Combinational polymorphisms of seven CXCL12-related genes are protective against breast cancer in Taiwan.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | NatGeo2}}